AACR: Colorectal Risk Cut in Half Among Patients Taking Thyroid Drug
1st Nov 2005, 20:35 GMT
BALTIMORE - Taking Levothyroxine (L-thyroxine) for at least five years appears to cut the risk for colorectal cancer in half, researchers reported here.
AACR: Colorectal Risk Cut in Half Among Patients Taking Thyroid Drug related news:
- New Study Shows Women More Vulnerable To Risk Of Colorectal Cancer From Tobacco — ScienceDaily Headlines: Health & Medicine
- Research unveils new, reliable approach to drug delivery for cancer patients — EurekAlert! - Cancer
- Cheek cells can detect lung cancer, says study — KeralaNext: Health
- Patients 'miss out' on clot care — BBC News | Health | UK Edition
- Neurological disease raises risk of complications from flu — EurekAlert! - Infectious and Emerging Diseases
- An Analysis of Colorectal Cancer R&D, Including Information About 200 Companies Involved in Research and 200 Drug Projects — PR Web (The Free Wire Service) Medical Cancer
- Merck Lawyer Lauds Company Scientists, Questions Vioxx Plaintiff's Credibility — KeralaNext: International
- Viagra Found to Have Direct Effects on the Human Heart — Rednova News - Health
- Study: Drug testing halted by early success doesn't help patients — USATODAY.com Health - Top Stories
- Hanes Dye will lay off 144 in Winston-Salem — JournalNow News Updates